We're a Rare Breed Find out why.
Capabilities It's what we do.
- Strategic Consulting
- Creative Services
- Research & Analytics
Join Our Mailing List
All fields required. We respect your privacy and
do not provide information to third parties.
Engaging Solutions for all audiences.
What's the Latest from around the industry.
NHS announces new mental health pilot programme
Six pilot sites will drive the design of new mental health services for young... Read more
Genentech in $910 million cancer licensing deal
Company buys rights to experimental pan-RAF... Read more
NICE rejects Lilly’s Portrazza, but backs Bayer’s Xofigo and Amgen’s Imlygic
Cost regulators for the NHS in England and Wales have published final guidelines turning down... Read more